quick, quick TO ALL!!!!
Thursday June 26 6:03 AM EDT
Company Press Release
BIOLASE Technology ships first commercial production
run of Millennium Dental Systems to Germany
SAN CLEMENTE, Calif.--(BW HealthWire)--June 26, 1997--BIOLASE Technology, Inc.
(NASDAQ:BLTI) announced today that 10 Millennium(TM) HydroKinetic(TM) tissue cutting
systems were shipped to its distribution partner in Germany. The June shipments were
the first commercial production run of the innovative dental systems shipped under a $12
million minimum purchase agreement with the distributor.
``Having made substantial investments in manufacturing resources, our ability to reach
commercial production objectives on schedule represents a significant milestone
achieved by BIOLASE Technology,'' said Donald A. La Point, the Company's President and
Chief Executive Officer. ``We continue to ramp up production, and anticipate a
significantly greater output in the third quarter.
``Four of the ten dental systems will be used in teaching seminars by some of Germany's
leading dental professionals to train other dentists in the benefits and use of our
proprietary HydroKinetic tissue cutting technology specifically for hard-tissue applications.
In particular, the seminars will be used to establish Millennium -- and its use of water as
the cutting medium -- as the dental technology of choice in Germany. The other six
Millennium units will be delivered to members of the distribution organization for sale to
customers.''
Added La Point: ``In addition to being approved in Germany for hard-tissue use,
Millennium has also received CE certification, which allows its sale and use throughout
the European Community. BIOLASE has been actively engaged in the process of
establishing distributor-partner relationships outside of Germany and we believe that
there are excellent opportunities for us to begin shipping units into at least two new
countries by early 1998. With more than 400,000 dentists estimated to be practicing
overseas, as opposed to 150,000 domestically, the international market would appear to
be substantially larger than that in the United States.''
BIOLASE Technology, Inc. manufactures and markets advanced medical, dental and
surgical products, including specialized biomaterials for dentistry and other medical
specialties, and home health-care products. The Company's Millennium system
incorporates a unique patent-pending technology that utilizes electromagnetic energy
laser pulses to rapidly energize and transform small atomized water droplets into smaller
high-speed cutting particles. This technology provides for efficient cutting of enamel, bone
and soft tissue, and has applications in general and surgical dentistry, dermatology, and
orthopedic and other surgery. LaserBrush(TM), the Company's innovative consumer
dental maintenance system, uses light transmitted around the toothbrush bristles to
interact with the Company's proprietary toothpaste to whiten teeth and neutralize
bacteria in the mouth.
The matters discussed in this news release include forward looking statements which
are subject to various risks, uncertainties and other factors that could cause actual
results to differ materially from the results anticipated in such forward looking
statements. Such risks, uncertainties and other factors include, but are not limited to, the
effect of actions of third parties, including governmental officials, the timely development
and acceptance of new products, the impact of competitive products and pricing, and
other risks detailed from time-to-time in the Company's filings with the Securities and
Exchange Commission, including the reports on Forms 10-KSB and 10-Q. Actual results
may differ materially from those projected. These forward-looking statements represent
the Company's judgment as of the date of this release. The Company disclaims, however,
any intent or obligation to update these forward-looking statements.
Contact:
BIOLASE Technology, Inc.
Donald A. La Point, 714/361-1200
or
FIN/COM
Larry Selwitz, 714/645-8410
Thursday June 26 6:03 AM EDT
Company Press Release
BIOLASE Technology ships first commercial production
run of Millennium Dental Systems to Germany
SAN CLEMENTE, Calif.--(BW HealthWire)--June 26, 1997--BIOLASE Technology, Inc.
(NASDAQ:BLTI) announced today that 10 Millennium(TM) HydroKinetic(TM) tissue cutting
systems were shipped to its distribution partner in Germany. The June shipments were
the first commercial production run of the innovative dental systems shipped under a $12
million minimum purchase agreement with the distributor.
``Having made substantial investments in manufacturing resources, our ability to reach
commercial production objectives on schedule represents a significant milestone
achieved by BIOLASE Technology,'' said Donald A. La Point, the Company's President and
Chief Executive Officer. ``We continue to ramp up production, and anticipate a
significantly greater output in the third quarter.
``Four of the ten dental systems will be used in teaching seminars by some of Germany's
leading dental professionals to train other dentists in the benefits and use of our
proprietary HydroKinetic tissue cutting technology specifically for hard-tissue applications.
In particular, the seminars will be used to establish Millennium -- and its use of water as
the cutting medium -- as the dental technology of choice in Germany. The other six
Millennium units will be delivered to members of the distribution organization for sale to
customers.''
Added La Point: ``In addition to being approved in Germany for hard-tissue use,
Millennium has also received CE certification, which allows its sale and use throughout
the European Community. BIOLASE has been actively engaged in the process of
establishing distributor-partner relationships outside of Germany and we believe that
there are excellent opportunities for us to begin shipping units into at least two new
countries by early 1998. With more than 400,000 dentists estimated to be practicing
overseas, as opposed to 150,000 domestically, the international market would appear to
be substantially larger than that in the United States.''
BIOLASE Technology, Inc. manufactures and markets advanced medical, dental and
surgical products, including specialized biomaterials for dentistry and other medical
specialties, and home health-care products. The Company's Millennium system
incorporates a unique patent-pending technology that utilizes electromagnetic energy
laser pulses to rapidly energize and transform small atomized water droplets into smaller
high-speed cutting particles. This technology provides for efficient cutting of enamel, bone
and soft tissue, and has applications in general and surgical dentistry, dermatology, and
orthopedic and other surgery. LaserBrush(TM), the Company's innovative consumer
dental maintenance system, uses light transmitted around the toothbrush bristles to
interact with the Company's proprietary toothpaste to whiten teeth and neutralize
bacteria in the mouth.
The matters discussed in this news release include forward looking statements which
are subject to various risks, uncertainties and other factors that could cause actual
results to differ materially from the results anticipated in such forward looking
statements. Such risks, uncertainties and other factors include, but are not limited to, the
effect of actions of third parties, including governmental officials, the timely development
and acceptance of new products, the impact of competitive products and pricing, and
other risks detailed from time-to-time in the Company's filings with the Securities and
Exchange Commission, including the reports on Forms 10-KSB and 10-Q. Actual results
may differ materially from those projected. These forward-looking statements represent
the Company's judgment as of the date of this release. The Company disclaims, however,
any intent or obligation to update these forward-looking statements.
Contact:
BIOLASE Technology, Inc.
Donald A. La Point, 714/361-1200
or
FIN/COM
Larry Selwitz, 714/645-8410 |
